Faeth Therapeutics, Inc. (FTH)
38.93
-0.19
(-0.49%)
USD |
NASDAQ |
Sep 03, 13:39
Faeth Therapeutics Debt to Equity Ratio : 0.0033 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0033 |
| March 31, 2026 | 0.0054 |
| December 31, 2025 | 0.0812 |
| September 30, 2025 | 0.0878 |
| June 30, 2025 | 0.0937 |
| March 31, 2025 | 0.1003 |
| December 31, 2024 | 0.1002 |
| September 30, 2024 | 0.0976 |
| June 30, 2024 | 0.0967 |
| March 31, 2024 | 0.0964 |
| December 31, 2023 | 0.0957 |
| September 30, 2023 | 0.0954 |
| June 30, 2023 | 0.0917 |
| March 31, 2023 | 0.0817 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0777 |
| September 30, 2022 | 0.0737 |
| June 30, 2022 | 0.0689 |
| March 31, 2022 | 0.067 |
| December 31, 2021 | 0.0161 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.0035 |
| March 31, 2021 | 0.0033 |
| December 31, 2020 | 0.0357 |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -0.7603 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics, Inc. | 0.0122 |
| Praxis Precision Medicines, Inc. | 0.0008 |
| Opus Genetics, Inc. | -2.788 |
| Jade Biosciences, Inc. | 0.0014 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 189.31M |
| Total Liabilities (Quarterly) | 9.581M |
| Shareholders Equity (Quarterly) | 179.72M |
| Current Ratio | 19.69 |
| Net Debt Paydown Yield | 0.08% |